We are live on ! Find out more
ACGN

Aceragen Inc

Delisted

ACGN was delisted on the 21st of August, 2023.

106 hedge funds and large institutions have $151M invested in Aceragen Inc in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 38 increasing their positions, 14 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 6

171% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 14

44% more capital invested

Capital invested by funds: $105M → $151M (+$46.2M)

36% more funds holding

Funds holding: 78106 (+28)

4% more call options, than puts

Call options by funds: $340K | Put options by funds: $327K

Holders
106
Holders Change
+28
Holders Change %
+35.9%
% of All Funds
2.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
34
Increased
38
Reduced
14
Closed
6
Calls
$340K
Puts
$327K
Net Calls
+$13K
Net Calls Change
+$61K

ACGN Hedge Fund Activity: Q4 2017 in Review

106 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Aceragen Inc (ACGN) for Q4 2017, worth a combined $151M — up 44% from $105M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ACGN positions and 6 closed out — a net gain of 28 holders — while 38 added to existing stakes and 14 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $16.8M. The largest seller was Broadfin Capital, cutting an estimated $839K.

  • 106 institutional investors held Aceragen Inc (ACGN) as of Q4 2017, up from 78 in Q3 2017.
  • Funds reported $151M of Aceragen Inc stock for Q4 2017, up 44% quarter-over-quarter.
  • 34 funds opened new Aceragen Inc positions in Q4 2017 and 6 closed out, a net change of +28 holders.
  • The largest Aceragen Inc buyer in Q4 2017 was Baker Bros. Advisors, an estimated $16.8M added.
  • The largest Aceragen Inc seller in Q4 2017 was Broadfin Capital, an estimated $839K sold.

Based on aggregated 13F filings for Q4 2017.